BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28814802)

  • 1. Relationship between necrotic patterns in glioblastoma and patient survival: fractal dimension and lacunarity analyses using magnetic resonance imaging.
    Liu S; Wang Y; Xu K; Wang Z; Fan X; Zhang C; Li S; Qiu X; Jiang T
    Sci Rep; 2017 Aug; 7(1):8302. PubMed ID: 28814802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
    Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
    Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging-based 3-dimensional fractal dimension and lacunarity analyses may predict the meningioma grade.
    Park YW; Kim S; Ahn SS; Han K; Kang SG; Chang JH; Kim SH; Lee SK; Park SH
    Eur Radiol; 2020 Aug; 30(8):4615-4622. PubMed ID: 32274524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
    Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
    Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape matters: morphological metrics of glioblastoma imaging abnormalities as biomarkers of prognosis.
    Curtin L; Whitmire P; White H; Bond KM; Mrugala MM; Hu LS; Swanson KR
    Sci Rep; 2021 Dec; 11(1):23202. PubMed ID: 34853344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients.
    Molina D; Pérez-Beteta J; Martínez-González A; Sepúlveda JM; Peralta S; Gil-Gil MJ; Reynes G; Herrero A; De Las Peñas R; Luque R; Capellades J; Balaña C; Pérez-García VM
    PLoS One; 2016; 11(8):e0161484. PubMed ID: 27557121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractal analysis: fractal dimension and lacunarity from MR images for differentiating the grades of glioma.
    Smitha KA; Gupta AK; Jayasree RS
    Phys Med Biol; 2015 Sep; 60(17):6937-47. PubMed ID: 26305773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer-extracted MR imaging features are associated with survival in glioblastoma patients.
    Mazurowski MA; Zhang J; Peters KB; Hobbs H
    J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomic Analysis Reveals Prognostic Information in T1-Weighted Baseline Magnetic Resonance Imaging in Patients With Glioblastoma.
    Ingrisch M; Schneider MJ; Nörenberg D; Negrao de Figueiredo G; Maier-Hein K; Suchorska B; Schüller U; Albert N; Brückmann H; Reiser M; Tonn JC; Ertl-Wagner B
    Invest Radiol; 2017 Jun; 52(6):360-366. PubMed ID: 28079702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
    Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
    Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
    Czarnek N; Clark K; Peters KB; Mazurowski MA
    J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.
    Chang L; Zhang P; Zhao D; Liu H; Wang Q; Li C; Du W; Liu X; Zhang H; Zhang Z; Jiang C
    Tumour Biol; 2016 Mar; 37(3):3979-86. PubMed ID: 26482617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.
    Wen Q; Jalilian L; Lupo JM; Molinaro AM; Chang SM; Clarke J; Prados M; Nelson SJ
    J Neurooncol; 2015 Jan; 121(2):331-9. PubMed ID: 25351579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractal dimension and lacunarity of tumor microscopic images as prognostic indicators of clinical outcome in early breast cancer.
    Pribic J; Vasiljevic J; Kanjer K; Konstantinovic ZN; Milosevic NT; Vukosavljevic DN; Radulovic M
    Biomark Med; 2015; 9(12):1279-7. PubMed ID: 26612586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
    Niyazi M; Pitea A; Mittelbronn M; Steinbach J; Sticht C; Zehentmayr F; Piehlmaier D; Zitzelsberger H; Ganswindt U; Rödel C; Lauber K; Belka C; Unger K
    Oncotarget; 2016 Jul; 7(29):45764-45775. PubMed ID: 27302927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and survival of patients harboring histological variants of glioblastoma.
    Ortega A; Nuño M; Walia S; Mukherjee D; Black KL; Patil CG
    J Clin Neurosci; 2014 Oct; 21(10):1709-13. PubMed ID: 24980627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Diagnostic Performance of Two-Dimensional and Three-Dimensional Fractal Dimension and Lacunarity Analyses for Predicting the Meningioma Grade.
    Kim S; Park YW; Park SH; Ahn SS; Chang JH; Kim SH; Lee SK
    Brain Tumor Res Treat; 2020 Apr; 8(1):36-42. PubMed ID: 32390352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.